BioSpace News Archive

Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced that it has amended its Sixth Amended and Restated Certificate of Incorporation to reflect a 1-for-10 reverse stock split of its common stock, which will be effective at 5:00 p.m. Pacific Time on June 4, 2019.

On May 14, 2019, Novus Medical Detox Center was an exhibitor/sponsor for the Pasco County ASAP Conference on “Strengthening Our Communities on Mental Health and Drug Prevention” with over 500 attendees of concerned professionals from the community.

Novitas Solutions, Inc. (Novitas) has been awarded the Jurisdiction H (JH) contract by the Centers for Medicare & Medicaid Services (CMS

Smart Meter, a diabetes management data, technology and solutions company, known for the iGlucose® Cellular Diabetes Care Solution, is pleased to announce the launch of a digital resource, www.ReimbursableRPM.com.

Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for life-threatening food allergies, announced new data from two studies that assessed the psychosocial burden of living with peanut allergy.

VentureMed Group, Inc., a privately-held medical device innovator in vessel preparation for interventional treatment of peripheral arterial disease and stenoses of arteriovenous fistulas and grafts, announced new data presented at the 20th Annual New Cardiovascular Horizons Annual Conference, May 29-31, in New Orleans, Louisiana.

For the first time, a new report analyzes Medicare’s mandatory bundling program known as Comprehensive Care for Joint Replacement, or CJR, from the state perspective.

Northwest Biotherapeutics announced highlights from Dr. Marnix Bosch’s Program Update in the Industry Expert Theater presentation at the 55th annual ASCO Conference, which was publicly webcast and was posted on the home page of the Company’s website at www.nwbio.com.

PDI, a leader in infection prevention products and solutions, will showcase two breakthrough product innovations at the 46th Annual Association for Professionals in Infection Control and Epidemiology Conference (APIC) in Philadelphia from June 12 through June 14.

With the mission of providing state-of-the-art education and training in the fast-emerging field of biopharmaceutical processing, the Jefferson Institute for Bioprocessing formally opened its doors May 31 with a ribbon-cutting ceremony, tours and symposium.